Clinical Trials Browser

Phase 1 × Advanced Nonhematologic Malignancies × Paclitaxel × Clear all

NCT02327169 2020-02-25

A Study MLN2480 in Combination With MLN0128 or Alisertib, or Paclitaxel, or Cetuximab, or Irinotecan in Adult Participants With Advanced Nonhematologic Malignancies

Phase 1 Completed

81 enrolled 33 charts

Advanced Nonhematologic Malignancies